IL6 and Bartsocas-Papas syndrome 1: This phenomenon is consistent with serological evidence—elevated levels of inflammatory markers such as CRP and IL-6 in IC/BPS patients suggest a synergistic effect between systemic inflammation and the local immune microenvironment.